Log in
Enquire now

List of Sequoia Pharmaceuticals patents

List of Sequoia Pharmaceuticals patents
List of G&K Services patents
List of Ruckus Wireless patents
List of Precision Planting patents
List of 500startups Batch 7 companies
CEOs of employment companies
Patents where
Current Assignee
Name
is
Sequoia PharmaceuticalsSequoia Pharmaceuticals
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 7151163 Antiviral agents for the treatment, control and prevention of infections by coronaviruses

Patent 7151163 was granted and assigned to Sequoia Pharmaceuticals on December, 2006 by the United States Patent and Trademark Office.

Sequoia Pharmaceuticals
Sequoia Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
7151163
December 19, 2006
‌
US Patent 7378441 Resistance-repellent retroviral protease inhibitors

Patent 7378441 was granted and assigned to Sequoia Pharmaceuticals on May, 2008 by the United States Patent and Trademark Office.

Sequoia Pharmaceuticals
Sequoia Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
7378441
May 27, 2008
‌
US Patent 7109230 Resistance-repellent retroviral protease inhibitors

Patent 7109230 was granted and assigned to Sequoia Pharmaceuticals on September, 2006 by the United States Patent and Trademark Office.

Sequoia Pharmaceuticals
Sequoia Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
7109230
September 19, 2006
‌
US Patent 9403789 Benzofuran-containing amino acid inhibitors of cytochrome P450

Patent 9403789 was granted and assigned to Sequoia Pharmaceuticals on August, 2016 by the United States Patent and Trademark Office.

Sequoia Pharmaceuticals
Sequoia Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
9403789
August 2, 2016
‌
US Patent 8703700 Bimacrocylic HCV NS3 protease inhibitors

Patent 8703700 was granted and assigned to Sequoia Pharmaceuticals on April, 2014 by the United States Patent and Trademark Office.

Sequoia Pharmaceuticals
Sequoia Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
8703700
April 22, 2014
‌
US Patent 7807845 Resistance-repellent retroviral protease inhibitors

Patent 7807845 was granted and assigned to Sequoia Pharmaceuticals on October, 2010 by the United States Patent and Trademark Office.

Sequoia Pharmaceuticals
Sequoia Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
7807845
October 5, 2010
‌
US Patent 8952056 Methods for inhibiting drug degradation

Patent 8952056 was granted and assigned to Sequoia Pharmaceuticals on February, 2015 by the United States Patent and Trademark Office.

Sequoia Pharmaceuticals
Sequoia Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
8952056
February 10, 2015
‌
US Patent 8906647 Diamide inhibitors of cytochrome P450

Patent 8906647 was granted and assigned to Sequoia Pharmaceuticals on December, 2014 by the United States Patent and Trademark Office.

Sequoia Pharmaceuticals
Sequoia Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
8906647
December 9, 2014
‌
US Patent 8481520 Compositions and methods for inhibiting cytochrome P450

Patent 8481520 was granted and assigned to Sequoia Pharmaceuticals on July, 2013 by the United States Patent and Trademark Office.

Sequoia Pharmaceuticals
Sequoia Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
8481520
July 9, 2013
‌
US Patent 7507763 Resistance-repellent retroviral protease inhibitors

Patent 7507763 was granted and assigned to Sequoia Pharmaceuticals on March, 2009 by the United States Patent and Trademark Office.

Sequoia Pharmaceuticals
Sequoia Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
7507763
March 24, 2009
‌
US Patent 8673970 HIV protease inhibitor and cytochrome p450 inhibitor combinations

Patent 8673970 was granted and assigned to Sequoia Pharmaceuticals on March, 2014 by the United States Patent and Trademark Office.

Sequoia Pharmaceuticals
Sequoia Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
8673970
March 18, 2014
‌
US Patent 8389571 Benzofuran derived HIV protease inhibitors

Patent 8389571 was granted and assigned to Sequoia Pharmaceuticals on March, 2013 by the United States Patent and Trademark Office.

Sequoia Pharmaceuticals
Sequoia Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
8389571
March 5, 2013
‌
US Patent 8048871 Compositions and methods for inhibiting cytochrome P450

Patent 8048871 was granted and assigned to Sequoia Pharmaceuticals on November, 2011 by the United States Patent and Trademark Office.

Sequoia Pharmaceuticals
Sequoia Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
8048871
November 1, 2011
‌
US Patent 7981929 Benzofuran derived HIV protease inhibitors

Patent 7981929 was granted and assigned to Sequoia Pharmaceuticals on July, 2011 by the United States Patent and Trademark Office.

Sequoia Pharmaceuticals
Sequoia Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
7981929
July 19, 2011
‌
US Patent 8569364 5-substituted benzofurans as inhibitors of cytochrome P450 2D6

Patent 8569364 was granted and assigned to Sequoia Pharmaceuticals on October, 2013 by the United States Patent and Trademark Office.

Sequoia Pharmaceuticals
Sequoia Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
8569364
October 29, 2013
15 results
0 selected
15 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us